Market›Health Care›Health Care Equipment & Supplies›Health Care Supplies
NEXGEL INC Warrant 12/17/2026

NXGLW

$0.05Mar 06, 2026 – Apr 27, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Supplies$0M
MVM
+$0.0M
TD Variance
3.371

Every news event mapped to its market reaction — 14 events, 2 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-03-10+41.9%legalSEC EDGARNXGLW 8-K: 1.01, 8.01 (SEC Filing)
2026-03-31-3.7%newsGlobeNewswireNEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
2026-04-08-3.1%newsGlobeNewswireNEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
2026-03-25+1.2%newsGlobeNewswireNEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st
2026-04-15-1.0%newsGlobeNewswireNEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
2026-04-17-1.0%newsGlobeNewswireNEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
2026-04-09-0.5%earningsGuruFocus.comNexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...
2026-04-21-0.4%M&AGlobeNewswireNEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
2026-04-21-0.4%newsGlobeNewswireCelularity Announces Closing of Transaction with NexGel
2026-04-21-0.4%earningsMobyNEXGEL, Inc. Q4 2025 Earnings Call Summary
2026-04-21-0.4%earningsSeeking AlphaNEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition
2026-04-21-0.4%earningsSeeking AlphaNEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
2026-04-21-0.4%legalSEC EDGARNXGLW 8-K: 1.01, 2.01, 2.03, 3.02, 8.01 (SEC Filing)
2026-04-27—executiveGlobeNewswireNEXGEL Appoints Ian Blackman as Chief Financial Officer
tickerdossier.comtickerdossier.substack.com